Colorectal cancer (CRC) is a serious health problem throughout the world. 5-Flurouracil, the first-line
chemotherapy of
colorectal cancer often produces more toxicity to neighboring cells; however, it is still used for CRC treatment. To overcome this,
umbelliferone (UMB), a less toxic
bioflavonoid has been used to test its anticancer effects on animal model. The objective of the present study is to evaluate the anticancer activity of UMB on
1,2-dimethylhydrazine (
DMH)-induced rat colon
tumorigenesis to determine the development of
aberrant crypt foci (ACF), agyrophylic nucleolar organizer regions (
AgNORs), mast cell recruitment, pro-inflammatory
cytokines such as
tumor necrosis factor (TNF)-α,
interleukin (IL)-1β and also study the expressions of
inducible nitric oxide synthase,
cyclooxygenase (COX)-2, and apoptotic markers.
DMH-induced rats showed increased ACF number (incidence), multiplicity and its distribution, counts of
AgNORs, mast cells, inflammatory markers and apoptotic
proteins. Interestingly, UMB supplementation to
DMH-induced rats (group 4) significantly (p < 0.05) suppressed ACF development,
AgNORs, mast cells, and inflammatory markers and increased the apoptotic markers as compared to
DMH-induced rats (group 2). We concluded that UMB is a potential
anticancer agent that can be used for the prevention and treatment of CRC.